Kaifeng Hui Lai Biological Technology Co., Ltd.

Company Details

  • Operational Address : (Inside Kaifeng Kaikang Pharmacy Co., Ltd.) Dongdi Waiyan, Bianjing Road, Kaifeng, Henan, China (Mainland)
  • Business Type : Manufacturer, Trading Company
  • Location : Henan, China (Mainland)
  • Year Established : 2013
  • Number Of Employees : 101 - 200 People
  • Export Percentage :
  • Production Lines :
  • R&D Staff :
  • Total Annual Revenue : Below US$1 Million
  • Main Markets : South Asia
  • Main Products : Cefuroxime Acid, Ceftezole Acid, Cefazonlin Acid, Cefotiam Hydrochloride Crude, Cefotaxime Acid
  • Country/Region : China
  • Links : China Chemicals, China Organic Intermediates, China Pharmaceutical Intermediates,
  • Company Introduction

    Kaifeng Huilai Bio-technology Co., Ltd. , located in Kaifeng which is a famous historic and cultural city of China, is a high-tech medicine and chemical production and operation intermediate enterprise covering the whole scientific research, production and marketing of bio-technology products. There are four production workshops and more than one hundred employees, 40 percent of who have college degree or above. The whole development, production and management staff of the company has been proved to be a knowledgeable, vigorous, progressive and innovative team. The company carries on the production quality management based on the GMP of drug production, and has passed through the ISO-9001 quality system certification. The Cefuroxime Acid Project is one of the key transformation and upgrading projects for the group company to specialize and strengthen. After putting the Cefuroxime Acid Project into production, the group company will become a complete pharmaceutical and intermediates industry chain and a rich product group, and devote itself to be a leading enterprise of domestic pharmaceutical intermediate industry. The new project, with the investment of 30 million RMB, has gone into trial production in May 2013. The production capacity of this project can reach 350 tons per year and gain more than 0.2 billion RMB in annual sales revenue.
    The company keeps on gaining all kinds of knowledge and concepts, and the pace with the times to build a specialization, information, modernization and innovation science-and-technology enterprise. In accordance with the operation principle of "Quality-oriented, Science first, Credible service, Win-win", the company commits itself to pharmaceutical intermediate production, and to be the professional supplier for the pharmaceutical and material requirement enterprises home and abroad to boost the healthy and sustainable development of its customer enterprises.
    Adhering to the principle-Quality and Service Come First, Huilai will always continues to provide the best pharmaceutical intermediate products, the most favorable price and the most thoughtful service for the friends and customer enterprises across the world.

    Company Information

  • Website : Visit website
  • Company Product

    • Cefotaxime Acid the third semi synthetic generation cephalosporin
    • Cefotaxime Sodium
    • Cefotiam
    • Ceftezole Acid sodium C13H12N804S3
    • Ceftezole Acid-manufacturer
    • Ceftezole Sodium for Injection-manufacturer
    • Cefuroxim-second generation of cephalosporin antibiotics
    • Cefuroxime Acid C16H16N4O8S
    • Cefuroxime acid C16H16N408S manufacturer
    • Cephalosporin antibiotics C16H16N408S
    • Cephalosporins cefuroxime octylic acid
    • Cephalosporins raw material the production of Cefotaxime sodium
    • Cephotaxime C16H17N5O7S2
    • DCC manufacturer C13H22N2
    • High quality and physicochemical octylic acid raw materials
    • Pharmaceutical intermediates C16H16N408S
    • ephalosporins cefuroxime octylic acid C16H16N4O8S